AWAK Technologies
Vivance, formerly AWAK Technologies, is a pioneering medical technology company focused on revolutionizing kidney care through innovative dialysis devices and digital solutions. Their product portfolio includes Viva Komfort, an automated peritoneal dialysis system with onsite fluid generation and advanced infection control; Viva Kompact, an ultraportable wearable dialysis device using patented sorbent-based dialysate regeneration technology; and Viva Konnect, a digital ecosystem integrating AI for personalized kidney care and remote patient monitoring. Vivance aims to reduce therapy burden, enhance quality of life, and enable personalized care for chronic kidney disease patients. The company is in the R&D and clinical trial phases, with significant milestones including FDA breakthrough device designations and ongoing pre-pivotal trials. Vivance operates globally with offices in Singapore, the United States, and India, and has raised over $20 million in funding, positioning itself as a leader in the kidney care innovation market.
AWAK Technologies
Vivance, formerly AWAK Technologies, is a pioneering medical technology company focused on revolutionizing kidney care through innovative dialysis devices and digital solutions. Their product portfolio includes Viva Komfort, an automated peritoneal dialysis system with onsite fluid generation and advanced infection control; Viva Kompact, an ultraportable wearable dialysis device using patented sorbent-based dialysate regeneration technology; and Viva Konnect, a digital ecosystem integrating AI for personalized kidney care and remote patient monitoring. Vivance aims to reduce therapy burden, enhance quality of life, and enable personalized care for chronic kidney disease patients. The company is in the R&D and clinical trial phases, with significant milestones including FDA breakthrough device designations and ongoing pre-pivotal trials. Vivance operates globally with offices in Singapore, the United States, and India, and has raised over $20 million in funding, positioning itself as a leader in the kidney care innovation market.